New guidelines for treatment of bipolar disorder CMAJ 1997;157:503 © 1997 Canadian Medical Association The Canadian Network for Mood and Anxiety Treatments (CANMAT) has published new guidelines concerning the treatment of patients with bipolar disorder. They emphasize early assessment and diagnosis and a combination of psychological and pharmacotherapeutic treatments. The guidelines, which are based on an extensive review of clinical research studies and a consensus of opinions of psychiatrists and general practitioners, incorporate new research on the limitations of using lithium in the treatment of bipolar disorder and recognize the role of new medications such as carbamazepine. CANMAT, which represents Canadian clinicians, teachers and researchers interested in promoting education, evidence-based practice and research in depression and bipolar and anxiety disorders, will publish the guidelines in the Sept. 1 issue of the Canadian Journal of Psychiatry. Send a letter to the editor responding to this article Envoyez une lettre à la rédaction au sujet de cet article | CMAJ September 1, 1997 (vol 157, no 5) / JAMC le 1er septembre 1997 (vol 157, no 5) |